Ginkgo Extract Is Safe in Patients with Hepatocellular Carcinoma and Does Not Affect Tumor Response, but It May Increase Survival
Hepatocellular carcinoma (HCC) is a type of liver cancer and is the third greatest cause of cancer-related death worldwide. When diagnosed in the advanced stage, it is associated with a poor prognosis and death after a median of 6 months if untreated. A common therapy is a sorafenib, which is an oral multikinase inhibitor that increases median survival times by
Read more